Skip Header

 
Contribute Send feedback

Reviewed, UniProtKB/Swiss-Prot P02749 (APOH_HUMAN)

Last modified November 25, 2008. Version 113. Feed History...

Clusters with 100%, 90%, 50% identity | Documents (6) | Third-party data | Customize display text xml rdf/xml gff fasta
Names and origin · Protein attributes · General annotation (Comments) · Ontologies · Sequence annotation (Features) · Sequences · References · Web resources · Cross-references · Entry information · Relevant documents

Names and origin

Protein namesRecommended name:
    Beta-2-glycoprotein 1
Alternative name(s):
    Beta-2-glycoprotein I
      Short name=Beta(2)GPI
      Short name=B2GPI
    Apolipoprotein H
      Short name=Apo-H
    Activated protein C-binding protein
    APC inhibitor
    Anticardiolipin cofactor
Gene names
Name: APOH
Synonyms: B2G1
OrganismHomo sapiens (Human)
Taxonomic identifier9606 [NCBI]
Taxonomic lineageEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomo

Protein attributes

Sequence length345 AA.
Sequence statusComplete.
Sequence processingThe displayed sequence is further processed into a mature form.
Protein existenceEvidence at protein level.

General annotation (Comments)

Function

Binds to various kinds of negatively charged substances such as heparin, phospholipids, and dextran sulfate. May prevent activation of the intrinsic blood coagulation cascade by binding to phospholipids on the surface of damaged cells.

Subcellular location

Secreted.

Tissue specificity

Expressed by the liver and secreted in plasma.

Miscellaneous

In addition to the conflicts shown in the feature table, Ref.9 reports an N-glycosylation site at Asn-188.

Sequence similarities

Contains 4 Sushi (CCP/SCR) domains.

Ontologies

Keywords

   Cellular componentSecreted
   Coding sequence diversityPolymorphism
   DomainRepeat
Signal
Sushi
   LigandHeparin-binding
   PTMGlycoprotein
   Technical term3D-structure
Direct protein sequencing

Gene Ontology (GO)

   Biological processblood coagulation, intrinsic pathway

Inferred from direct assay. Source: UniProtKB

negative regulation of angiogenesis

Inferred from direct assay. Source: UniProtKB

negative regulation of endothelial cell migration

Inferred from direct assay. Source: UniProtKB

negative regulation of endothelial cell proliferation

Inferred from direct assay. Source: UniProtKB

negative regulation of fibrinolysis

Inferred from direct assay. Source: UniProtKB

negative regulation of myeloid cell apoptosis

Inferred from direct assay. Source: UniProtKB

negative regulation of smooth muscle cell apoptosis

Inferred from direct assay. Source: UniProtKB

plasminogen activation

Inferred from direct assay. Source: UniProtKB

positive regulation of blood coagulation

Traceable author statement. Source: UniProtKB

positive regulation of lipoprotein lipase activity

Inferred from direct assay. Source: UniProtKB

triacylglycerol metabolic process

Inferred from direct assay. Source: UniProtKB

triacylglycerol transport

Inferred from sequence or structural similarity. Source: UniProtKB

   Cellular componentcell surface

Inferred from direct assay. Source: UniProtKB

chylomicron

Inferred from direct assay. Source: UniProtKB

cytoplasm

Inferred from direct assay. Source: HPA

high-density lipoprotein particle

Inferred from direct assay. Source: UniProtKB

nucleus

Inferred from direct assay. Source: HPA

very-low-density lipoprotein particle

Inferred from direct assay. Source: UniProtKB

   Molecular functioneukaryotic cell surface binding

Inferred from direct assay. Source: UniProtKB

glycoprotein binding

Inferred from physical interaction. Source: UniProtKB

heparin binding

Inferred from electronic annotation. Source: UniProtKB-KW

lipoprotein lipase activator activity

Inferred from direct assay. Source: UniProtKB

phospholipid binding

Inferred from direct assay. Source: UniProtKB

Complete GO annotation...

Sequence annotation (Features)

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifier

Molecule processing

Signal peptide1 – 1919
Chain20 – 345326Beta-2-glycoprotein 1
PRO_0000002059

Regions

Domain21 – 8161Sushi 1
Domain82 – 13958Sushi 2
Domain140 – 20263Sushi 3
Domain203 – 26260Sushi 4
Region263 – 34583Sushi-like

Amino acid modifications

Glycosylation1491O-linked (GalNAc...)
Glycosylation1621N-linked (GlcNAc...)
Glycosylation1831N-linked (GlcNAc...)
Glycosylation1931N-linked (GlcNAc...)
Glycosylation2531N-linked (GlcNAc...)
Disulfide bond23 ↔ 66
Disulfide bond51 ↔ 79
Disulfide bond84 ↔ 124
Disulfide bond110 ↔ 137
Disulfide bond142 ↔ 188
Disulfide bond174 ↔ 200
Disulfide bond205 ↔ 248
Disulfide bond234 ↔ 260
Disulfide bond264 ↔ 315
Disulfide bond300 ↔ 325
Disulfide bond307 ↔ 345

Natural variations

Natural variant1071S → N in allele APOH*1. dbSNP rs1801692.
VAR_008169
Natural variant1541R → H
VAR_019155
Natural variant2661V → L in 23% of the population. dbSNP rs4581.
VAR_000673
Natural variant3251C → G Loss of phosphatidylserine-binding. dbSNP rs1801689.
VAR_008170
Natural variant3351W → S in allele APOH*3W; loss of phosphatidylserine-binding. dbSNP rs1801690.
VAR_008171

Experimental info

Sequence conflict1211S → C AA sequence Ref.9
Sequence conflict1881C → N AA sequence Ref.9

Secondary structure

....................................................................... 345
Helix Strand Turn

Details...

Sequences

Sequence LengthMass (Da)Tools
P02749-1 [UniParc].

Last modified June 1, 1994. Version 3.
Checksum: 63101704F8EDFE3F

FASTA34538,298
        10         20         30         40         50         60 
MISPVLILFS SFLCHVAIAG RTCPKPDDLP FSTVVPLKTF YEPGEEITYS CKPGYVSRGG 

        70         80         90        100        110        120 
MRKFICPLTG LWPINTLKCT PRVCPFAGIL ENGAVRYTTF EYPNTISFSC NTGFYLNGAD 

       130        140        150        160        170        180 
SAKCTEEGKW SPELPVCAPI ICPPPSIPTF ATLRVYKPSA GNNSLYRDTA VFECLPQHAM 

       190        200        210        220        230        240 
FGNDTITCTT HGNWTKLPEC REVKCPFPSR PDNGFVNYPA KPTLYYKDKA TFGCHDGYSL 

       250        260        270        280        290        300 
DGPEEIECTK LGNWSAMPSC KASCKVPVKK ATVVYQGERV KIQEKFKNGM LHGDKVSFFC 

       310        320        330        340 
KNKEKKCSYT EDAQCIDGTI EVPKCFKEHS SLAFWKTDAS DVKPC 

« Hide

References

« Hide 'large scale' references
[1]"Complete nucleotide and deduced amino acid sequence of human beta 2-glycoprotein I."
Steinkasserer A., Estaller C., Weiss E., Sim R.B., Day A.J.
Biochem. J. 277:387-391(1991) [PubMed: 1650181] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA].
Tissue: Liver.
[2]"Molecular cloning and mammalian expression of human beta 2-glycoprotein I cDNA."
Kristensen T., Schousboe I., Boel E., Mulvihill E.M., Hansen R.R., Moeller K.B., Moeller N.P.H., Sottrup-Jensen L.
FEBS Lett. 289:183-186(1991) [PubMed: 1655523] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA].
Tissue: Liver.
[3]"Nucleotide sequence and expression of the human gene encoding apolipoprotein H (beta 2-glycoprotein I)."
Mehdi H., Nunn M., Steel D.M., Whitehead A.S., Perez M., Walker L., Peeples M.E.
Gene 108:293-298(1991) [PubMed: 1748314] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA].
Tissue: Liver.
[4]"Molecular cloning and sequence analysis of the cDNA encoding human apolipoprotein H (beta 2-glycoprotein I)."
Day J.R., O'Hara P.J., Grant F.J., Lofton-Day C.E., Berkaw M.N., Werner P., Arnaud P.
Int. J. Clin. Lab. Res. 21:256-263(1992) [PubMed: 1339416] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA].
[5]"Molecular definition of human beta 2-glycoprotein I (beta 2-GPI) by cDNA cloning and inter-species differences of beta 2-GPI in alternation of anticardiolipin binding."
Matsuura E., Igarashi M., Igarashi Y., Nagae H., Ichikawa K., Yasuda T., Koike T.
Int. Immunol. 3:1217-1221(1991) [PubMed: 1777418] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA].
[6]"Structure of the human beta2-glycoprotein I (apolipoprotein H) gene."
Okkels H., Rasmussen T.E., Sanghera D.K., Kamboh M.I., Kristensen T.
Eur. J. Biochem. 259:435-440(1999) [PubMed: 9914524] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA].
[7]SeattleSNPs program for genomic applications
Submitted (JUN-2003) to the EMBL/GenBank/DDBJ databases
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANTS ASN-107; HIS-154; LEU-266 AND SER-335.
[8]"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
The MGC Project Team
Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
Tissue: Liver.
[9]"Complete amino acid sequence of human plasma beta 2-glycoprotein I."
Lozier J., Takahashi N., Putnam F.W.
Proc. Natl. Acad. Sci. U.S.A. 81:3640-3644(1984) [PubMed: 6587378] [Abstract]
Cited for: PROTEIN SEQUENCE OF 20-345, GLYCOSYLATION AT ASN-162; ASN-183; ASN-193 AND ASN-253, DISULFIDE BONDS.
[10]"Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor."
Matsuura E., Igarashi Y., Fujimoto M., Ichikawa K., Suzuki T., Sumida T., Yasuda T., Koike T.
J. Immunol. 148:3885-3891(1992) [PubMed: 1602135] [Abstract]
Cited for: PROTEIN SEQUENCE OF 20-44.
[11]"Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H)."
McNeil H.P., Simpson R.J., Chesterman C.N., Krilis S.A.
Proc. Natl. Acad. Sci. U.S.A. 87:4120-4124(1990) [PubMed: 2349221] [Abstract]
Cited for: PROTEIN SEQUENCE OF 20-43.
[12]"Purification of apolipoprotein H (beta 2-glycoprotein I)-like protein from human follicular fluid."
Aleporou-Marinou V., Pappa H., Yalouris P., Patargias T.
Comp. Biochem. Physiol. 128B:537-542(2001) [PubMed: 11250549] [Abstract]
Cited for: PROTEIN SEQUENCE OF 20-38.
Tissue: Ovarian follicular fluid.
[13]"Activity, disulphide mapping and structural modelling of the fifth domain of human beta 2-glycoprotein I."
Steinkkasserer A., Barlow P.N., Willis A.C., Kertesz Z., Campbell I.D.,